title: Reply to "the brain, amphotericin B, and p-glycoprotein".
authors: Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
authors: Ji-Qin
authors: JQ
authors: Wu
authors: Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China.
authors: Kun
authors: K
authors: Shao
authors: Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China.
authors: Chen
authors: C
authors: Jiang
authors: Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China zhulp@fudan.edu.cn.
authors: Li-Ping
authors: LP
authors: Zhu
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors*; D000666:Amphotericin B / Q000493:pharmacokinetics*; D000818:Animals; D000935:Antifungal Agents / Q000493:pharmacokinetics*; D001812:Blood-Brain Barrier / Q000187:drug effects*; D003453:Cryptococcosis / Q000188:drug therapy*; D008297:Male; D014700:Verapamil / Q000494:pharmacology*
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000935:Antifungal Agents; D000666:Amphotericin B; D014700:Verapamil
references: Antimicrob Agents Chemother. 2014 Aug;58(8):4464-9
references: 24867970
references: Antimicrob Agents Chemother. 2015 Feb;59(2):1386
references: 25628395
references: Curr Med Chem. 2012;19(13):1946-2025
references: 22257057